LHRH analogue goserelin helps preserve fertility in hormone receptor-negative breast cancer
2.6 هزار بار بازدید -
10 سال پیش
-
Visit
Visit http://www.ecancer.org for more.
Dr Moore talks to ecancertv at ASCO 2014 about the findings from a federally funded phase III clinical trial, S0230/POEMS, which indicate that adding a hormone suppressing drug called goserelin to standard chemotherapy may be an effective method of preserving fertility among women with early-stage hormone receptor-negative breast cancer.
ecancer's filming at ASCO has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.
Dr Moore talks to ecancertv at ASCO 2014 about the findings from a federally funded phase III clinical trial, S0230/POEMS, which indicate that adding a hormone suppressing drug called goserelin to standard chemotherapy may be an effective method of preserving fertility among women with early-stage hormone receptor-negative breast cancer.
ecancer's filming at ASCO has been kindly supported by Amgen through the ECMS Foundation. ecancer is editorially independent and there is no influence over content.
10 سال پیش
در تاریخ 1393/05/20 منتشر شده
است.
2,640
بـار بازدید شده